An alternative approach to myelodysplasia management: aggressive observation and prompt intervention.

J. Teichman,H. Scherz,Kyung Do Kim,D. Cho,M. Packer,G. Kaplan

DOI: https://doi.org/10.1016/S0022-5347(17)32716-7

1994-08-01

Abstract:

What problem does this paper attempt to address?

A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity

James A Shayman,Akira Abe,Miki Hiraoka

DOI: https://doi.org/10.1023/B:GLYC.0000016739.32089.55

Abstract:A series of inhibitors of glucosylceramide synthesis, the PDMP based family of compounds, has been developed as a tool for the study of sphingolipid biochemistry and biology. During the course of developing more active glucosylceramide synthase inhibitors, we identified a second site of inhibitory activity for PDMP and its structural homologues that accounted for the ability of the inhibitors to raise cell and tissue ceramide levels. This inhibitory activity was directed against a previously unknown pathway for ceramide metabolism, viz. the formation of 1- O -acylceramide. In this pathway the addition of a fatty acyl group to the primary hydroxyl of ceramide occurs through a transacylation with either phosphatidylethanolamine or phosphatidylcholine as a substrate. However, both in the absence and presence of ceramide, water serves as an acceptor for the fatty acid. Thus the enzyme may be considered to be a phospholipase A2. The enzyme is unique in that it has an acidic pH optimum and is localized to lysosomes by cell fractionation. More recently, the 1- O -acylceramide synthase has been purified, sequenced, and cloned. This phospholipase A2 was discovered to be structurally homologous to lecithin cholesterol acyltransferase (LCAT). However, this phospholipase A2 does not recognize cholesterol and lacks the defined lipoprotein-binding domain present in LCAT. We now refer to this enzyme as lysosomal phospholipase A2 (LPLA2). Although acidic phospholipase A2 activities have been previously identified, LPLA2 appears to be the first lysosomal PLA2 to have been sequenced. This new phospholipase A2 lacks an obvious and proven biological function.
Identification and Functional Analysis of Cytosolic Phospholipase A2 (cpla2) from the Red Swamp Crayfish Procambarus Clarkii: the First Evidence of Cpla2 Involved in Immunity in Invertebrates.

Chen-Yang Lin,Wen-Bin Xu,Bang-Ze Li,Miao-An Shu,Yan-Mei Zhang

DOI: https://doi.org/10.1016/j.fsi.2023.108944

IF: 4.622

2023-01-01

Fish & Shellfish Immunology

Abstract:Cytosolic phospholipase A2 (cPLA2) specifically liberates the arachidonic acids from the phospholipid substrates. In mammals, cPLA2 serves as a key control point in inflammatory responses due to its diverse downstream products. However, the role of cPLA2 in animals lower than mammals largely remains unknown. In the current research, a homolog of cPLA2 was first identified and characterized in the red swamp crayfish Procambarus clarkii. The full-length cDNA of PccPLA2 was 4432 bp in length with a 3036 bp-long open reading frame, encoding a putative protein of 1011 amino acids that contained a protein kinase C conserved region 2 and a catalytic subunit of cPLA2. PccPLA2 was ubiquitously expressed in all examined tissues with the highest expression in the hepatopancreas, and the expression in hemocytes as well as hepatopancreas was induced upon the immune challenges of WSSV and Aeromonas hydrophila. After the co-treatment of RNA interference and bacterial infection, the decline of bacteria clearance capability was observed in the hemolymph, and the expression of some antimicrobial peptides (AMPs) was significantly suppressed. Additionally, the phagocytosis of A. hydrophila by primary hemocytes decreased when treated with the specific inhibitor CAY10650 of cPLA2. These results indicated the participation of PccPLA2 in both cellular and humoral immune responses in the crayfish, which provided an insight into the role that cPLA2 played in the innate immunity of crustaceans, and even in invertebrates.
Cloning and Characterization of an Oxiranedicarboxylate Hydrolase from Labrys Sp. WH-1

Wen-na Bao,Zi-sheng Luo,Shi-wang Liu,Yuan-feng Wu,Pei-lian Wei,Gong-nian Xiao,Yong Liu

DOI: https://doi.org/10.1631/jzus.b1900392

2019-01-01

Journal of Zhejiang University SCIENCE B

Abstract:This study aimed to clone and characterize the oxiranedicarboxylate hydrolase (ORCH) from Labrys sp. WH-1. Purification by column chromatography, characterization of enzymatic properties, gene cloning by protein terminal sequencing and polymerase chain reaction (PCR), and sequence analysis by secondary structure prediction and multiple sequence alignment were performed. The ORCH from Labrys sp. WH-1 was purified 26-fold with a yield of 12.7%. It is a monomer with an isoelectric point (pl) of 8.57 and molecular mass of 30.2 kDa. It was stable up to 55 °C with temperature at which the activity of the enzyme decreased by 50% in 15 min (T5015) of 61 °C and the half-life at 50 °C (t1/2, 50 °c) of 51 min and was also stable from pH 4 to 10, with maximum activity at 55 °C and pH 8.5. It is a metal-independent enzyme and strongly inhibited by Cu2+, Ag+, and anionic surfactants. Its kinetic parameters (Km, kcat, and kcat/Km) were 18.7 mmol/L, 222.3 s−1, and 11.9 mmol/(L·s), respectively. The ORCH gene, which contained an open reading frame (ORF) of 825 bp encoding 274 amino acid residues, was overexpressed in Escherichia coli and the enzyme activity was 33 times higher than that of the wild strain. The catalytic efficiency and thermal stability of the ORCH from Labrys sp. WH-1 were the best among the reported ORCHs, and it provides an alternative catalyst for preparation of l(+)-2,3-dihydrobutanedioic acid.
Heterologous Expression, Refolding, and Characterization of a Calcium-Independent Phospholipase A1 from Streptomyces Albidoflavus

Cheng, Shi,Guo, Zitao,Liang, Chaojuan,Shi, Yi,Geng, Peng,Xin, Yu,Gu, Zhenghua,Zhang, Liang

DOI: https://doi.org/10.1007/s43393-021-00070-8

2022-01-01

Systems Microbiology and Biomanufacturing

Abstract:Phospholipase A 1 (PLA 1 ) is a member of the hydrolase family with applications in various fields, especially in the food industry. A calcium-independent PLA 1 from Streptomyces albidoflavus was expressed in E. coli BL21 (DE3) in this study. The results indicated that the soluble expression of PLA 1 was at low level, which was possibly due to the toxicity of PLA 1 to the host. In contrast, the expression of the enzyme as inclusion bodies exhibited a high-level expression and 0.3 mg inclusion bodies protein could be derived from 1 mL culture medium. Furthermore, the renaturation of PLA 1 was achieved through a direct dilution method, yielding 29.6 U/mL PLA 1 activity after 16 h of renaturation at 4 °C. For improving the efficiency of the dilution refolding process, a continuous refolding strategy was established, and 155 U/mL PLA 1 activity was derived from the continuous refolding process. With soybean lecithin as the substrate, the specific activity of purified renatured PLA 1 was 1380 U/mg and the optimal temperature and pH was found to be 60 °C and 6.5. In addition, the renatured PLA 1 was observed with better activity towards phosphatidyl inositol, whilst lipase activity was detected when the catalyzing temperature was below 55 °C. Overall, this study provides a possible solution to obtain calcium-independent PLA 1 with high yield by heterologous expression in E. coli and hence to promote its further application in the field of food industry.
Overexpression, purification and characterization of phospholipase C from Acinetobacter calcoaceticus

Wang Yanhong,Zhang Liang,Gu Zhenghua,Ding Zhongyang,Shi Guiyang

DOI: https://doi.org/10.13343/j.cnki.wsxb.2014.10.015

2014-01-01

Abstract:In this study, we constructed two recombinant Escherichia coli strains to produce phospholipase C (PLC) from Acinetobacter calcoaceticus. The recombinant enzymes were purified to homogeneity and characterized. [Methods] We cloned the PLC encoding gene plc1, plc2 from genome DNA of A. calcoaceticus ATCC17902. The amplified fragments were inserted into pET28a(+ to obtain expression plasmids. E. coli BL21 (DE3) harboring the above plasmids were cultivated and induced with isopropyl-beta-D-thiogalactopyranoside to express PLCs. The recombinant PLCs were purified by affinity chromatography and their catalytic properties were characterized.Two PLCs from A. calcoaceticus were cloned and functional expressed in E. coli. The recombinant enzymes have activities of 31,160 +/- 418 U/mg for PLC1 and 13640 +/- 354 U/mg for PLC2, when using p-nitrophenyl phosphorycholine as substrate. The purified PLC1 and PLC2 exhibited optimum temperature at 65 degrees C and 50 degrees C, respectively. Their optimal pH were 8 and 7.5, respectively. PLC2 was stable under 40 degrees C and pH at 8, whereas the residual activity of PLC1 was less than 25% in the same condition. Mg2+ and Ca2+ stimulated two enzymes activity, whereas Zn2. stimulated PLC1 and inhibited PLC2. PLC1 and PLC2 hydrolyzed phosphatidylinositol.It is the first time to express and characterize the PLC gene from A. calcoaceticus ATCC17902. These research results provide reference for the study of food-safety microbiological PLC.
Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.

M. Sykes,M. W. Harty,G. Szot,D. Pearson

DOI: https://doi.org/10.1182/BLOOD.V83.9.2560.2560

IF: 20.3

1994-05-01

Blood

Abstract:We have recently shown that a short course of high-dose interleukin-2 (IL-2) can markedly inhibit the graft-versus-host disease (GVHD)-promoting activity of donor CD4+ T cells. The difficulty in dissociating GVHD-promoting from graft-versus-leukemia (GVL) effects of alloreactive donor T cells currently prevents clinical bone marrow transplantation (BMT) from fulfilling its full potential. To test the capacity of IL-2 treatment to promote such a dissociation, we have developed a new murine transplantable acute myelogenous leukemia model using a class II major histocompatibility complex-positive BALB/c Moloney murine leukemia virus-induced promonocytic leukemia, 2B-4-2. BALB/c mice receiving 2.5 x 10(5) 2B-4-2 cells intravenously 1 week before irradiation and syngeneic BMT died from leukemia within 2 to 4 weeks after BMT. Administration of syngeneic spleen cells and/or a 2.5-day course of IL-2 treatment alone did not inhibit leukemic mortality. In contrast, administration of non-T-cell-depleted fully allogeneic B10 (H-2b) spleen cells and T-cell-depleted B10 marrow led to a significant delay in leukemic mortality in IL-2-treated mice. In these animals GVHD was inhibited by IL-2 treatment. GVL effects were mediated entirely by donor CD4+ and CD8+ T cells. Remarkably, IL-2 administration did not diminish the magnitude of the GVL effect of either T-cell subset. This was surprising, because CD4-mediated GVHD was inhibited in the same animals in which CD4-mediated GVL effects were not reduced by IL-2 treatment. These results suggest a novel mechanism by which GVHD and GVL effects of a single unprimed alloreactive T-cell subset can be dissociated; different CD4 activities promote GVHD and GVL effects, and the former, but not the latter activities are inhibited by treatment with IL-2.
Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice.

W. Blankesteijn,E. E. Creemers,E. Lutgens,J. Cleutjens,M. Daemen,Jos F. M. Smits

DOI: https://doi.org/10.1046/J.1365-201X.2001.00887.X

2001-09-01

Acta Physiologica Scandinavica

Abstract:Recent improvements in the clinical management of acute myocardial infarction (MI) have resulted in a dramatic decrease in mortality because of this condition. This implies that more patients enter the process of infarct healing. This is a highly complex cascade of events which, although studied for decades, is still not completely understood. An increasing number of genetically altered mice can now be studied in a mouse model of MI, to investigate the contribution of the product of the targeted gene to the infarct healing process. In this review, we will discuss the defects in infarct healing that have been observed in null mutants for plasminogen, urokinase-type plasminogen activator (u-PA), matrix metalloproteinases (MMPS), thrombospondin-2 and dishevelled-1. These studies provide new insights in the infarct healing process itself, but may also help to define new diagnostic and therapeutic targets in humans suffering from MI.
Characterization of the transacylase activity of rat liver 60-kDa lysophospholipase-transacylase. Acyl transfer from the sn-2 to the sn-1 position

H Sugimoto,S Yamashita

DOI: https://doi.org/10.1016/s1388-1981(99)00059-1

1999-05-18

Abstract:Rat liver 60-kDa lysophospholipase-transacylase catalyzes not only the hydrolysis of 1-acyl-sn-glycero-3-phosphocholine, but also the transfer of its acyl chain to a second molecule of 1-acyl-sn-glycero-3-phosphocholine to form phosphatidylcholine (H. Sugimoto, S. Yamashita, J. Biol. Chem. 269 (1994) 6252-6258). Here we report the detailed characterization of the transacylase activity of the enzyme. The enzyme mediated three types of acyl transfer between donor and acceptor lipids, transferring acyl residues from: (1) the sn-1 to -1(3); (2) sn-1 to -2; and (3) sn-2 to -1 positions. In the sn-1 to -1(3) transfer, the sn-1 acyl residue of 1-acyl-sn-glycero-3-phosphocholine was transferred to the sn-1(3) positions of glycerol and 2-acyl-sn-glycerol, producing 1(3)-acyl-sn-glycerol and 1,2-diacyl-sn-glycerol, respectively. In the sn-1 to -2 transfer, the sn-1 acyl residue of 1-acyl-sn-glycero-3-phosphocholine was transferred to not only the sn-2 positions of 1-acyl-sn-glycero-3-phosphocholine, but also 1-acyl-sn-glycero-3-phosphoethanolamine, producing phosphatidylcholine and phosphatidylethanolamine, respectively. 1-Acyl-sn-glycero-3-phospho-myo-inositol and 1-acyl-sn-glycero-3-phosphoserine were much less effectively transacylated by the enzyme. In the sn-2 to -1 transfer, the sn-2 acyl residue of 2-acyl-sn-glycero-3-phosphocholine was transferred to the sn-1 position of 2-acyl-sn-glycero-3-phosphocholine and 2-acyl-sn-glycero-3-phosphoethanolamine, producing phosphatidylcholine and phosphatidylethanolamine, respectively. Consistently, the enzyme hydrolyzed the sn-2 acyl residue from 2-acyl-sn-glycero-3-phosphocholine. By the sn-2 to -1 transfer activity, arachidonic acid was transferred from the sn-2 position of donor lipids to the sn-1 position of acceptor lipids, thus producing 1-arachidonoyl phosphatidylcholine. When 2-arachidonoyl-sn-glycero-3-phosphocholine was used as the sole substrate, diarachidonoyl phosphatidylcholine was synthesized at a rate of 0.23 micromol/min/mg protein. Thus, 60-kDa lysophospholipase-transacylase may play a role in the synthesis of 1-arachidonoyl phosphatidylcholine needed for important cell functions, such as anandamide synthesis.
Role of conserved active site residues in catalysis by phospholipase B1 from Cryptococcus neoformans

Peter M Jones,Kylie M Turner,Julianne T Djordjevic,Tania C Sorrell,Lesley C Wright,Anthony M George

DOI: https://doi.org/10.1021/bi7009508

IF: 3.321

2007-09-04

Biochemistry

Abstract:Phospholipase B1 (PLB1), secreted by the pathogenic yeast Cryptococcus neoformans, has an established role in virulence. Although the mechanism of its phospholipase B, lysophospholipase, and lysophospholipase transacylase activities is unknown, it possesses lipase, subtilisin protease aspartate, and phospholipase motifs containing putative catalytic residues S146, D392, and R108, respectively, conserved in fungal PLBs and essential for human cytosolic phospholipase A2 (cPLA2) catalysis. To determine the role of these residues in PLB1 catalysis, each was substituted with alanine, and the mutant cDNAs were expressed in Saccharomyces cerevisiae. The mutant PLB1s were deficient in all three enzymatic activities. As the active site structure of PLB1 is unknown, a homology model was developed, based on the X-ray structure of the cPLA2 catalytic domain. This shows that the two proteins share a closely related fold, with the three catalytic residues located in identical positions as part of a single active site, with S146 and D392 forming a catalytic dyad. The model suggests that PLB1 lacks the "lid" region which occludes the cPLA2 active site and provides a mechanism of interfacial activation. In silico substrate docking studies with cPLA2 reveal the binding mode of the lipid headgroup, confirming the catalytic dyad mechanism for the cleavage of the sn-2 ester bond within one of two separate binding tracts for the lipid acyl chains. Residues specific for binding arachidonic and palmitic acids, preferred substrates for cPLA2 and PLB1, respectively, are identified. These results provide an explanation for differences in substrate specificity between lipases sharing the cPLA2 catalytic domain fold and for the differential effect of inhibitors on PLB1 enzymatic activities.
Mammalian Long-Chain Acyl-CoA Synthetases

Eric Soupene,Frans A. Kuypers

DOI: https://doi.org/10.3181/0710-mr-287

2008-05-01

Experimental Biology and Medicine

Abstract:Acyl-CoA synthetase enzymes are essential for de novo lipid synthesis, fatty acid catabolism, and remodeling of membranes. Activation of fatty acids requires a two-step reaction catalyzed by these enzymes. In the first step, an acyl-AMP intermediate is formed from ATP. AMP is then exchanged with CoA to produce the activated acyl-CoA. The release of AMP in this reaction defines the superfamily of AMP-forming enzymes. The length of the carbon chain of the fatty acid species defines the substrate specificity for the different acyl-CoA synthetases (ACS). On this basis, five sub-families of ACS have been characterized. The purpose of this review is to report on the large family of mammalian long-chain acyl-CoA synthetases (ACSL), which activate fatty acids with chain lengths of 12 to 20 carbon atoms. Five genes and several isoforms generated by alternative splicing have been identified and limited information is available on their localization. The structure of these membrane proteins has not been solved for the mammalian ACSLs but homology to a bacterial form, whose structure has been determined, points at specific structural features that are important for these enzymes across species. The bacterial form acts as a dimer and has a conserved short motif, called the fatty acid Gate domain, that seems to determine substrate specificity. We will discuss the characterization and identification of the different spliced isoforms, draw attention to the inconsistencies and errors in their annotations, and their cellular localizations. These membrane proteins act on membrane-bound substrates probably as homo- and as heterodimer complexes but have often been expressed as single recombinant isoforms, apparently purified as monomers and tested in Triton X-100 micelles. We will argue that such studies have failed to provide an accurate assessment of the activity and of the distinct function of these enzymes in mammalian cells.

medicine, research & experimental
Molecular Cloning and Functional Analysis of Secretory Phospholipase A2 from Apostichopus japonicus

Cheng Li,Lili Yang,Zhongyun Zhang,Ying Liu,Xu Li,Kai Yang,Ming Chen

DOI: https://doi.org/10.1007/s10528-024-10738-0

2024-03-20

Biochemical Genetics

Abstract:Secretory phospholipase A 2 (sPLA 2 ) plays important roles in phospholipid metabolism, skin barrier maintenance, immune response and other processes in organisms. sPLA 2 of sea cucumber A. japonicus (AjPLA 2 ) has not yet been reported. This study successfully amplified the AjPLA 2 sequence. The total cDNA of AjPLA 2 is 931 bp, including a 480 bp ORF that encodes 159 amino acids. The AjPLA 2 protein includes a 16-aa signal peptide, a 5-aa precursor peptide and a 138-aa mature peptide. Homologous alignment showed that AjPLA 2 and the sPLA 2 s from starfish have the typical domains of the Group IB sPLA 2 . And additional amino acid sequences were found around the β-Wing, which is different from the Group IB sPLA 2 . These results showed that AjPLA 2 and sPLA 2 s from starfish all belong to a new group in the Group I sPLA 2 family. AjPLA 2 is widely distributed in sea cucumber tissues. The functional analysis also showed that AjPLA 2 was upregulated in the intestine by feeding. When the body wall was damaged, it was significantly upregulated around the wound. And the expression levels of AjPLA 2 were significantly increased in V. splendens -infected sea cucumbers. The results indicated that AjPLA 2 plays roles in the sea cucumber immunologic process. Combined with the upregulation of unsaturated fatty acids (PUFAs) content in A. japonicus, it demonstrated that AjPLA 2 could participate in the immune of A. japonicus by hydrolyzing phospholipid and releasing PUFAs. This study had a solid foundation for the further research of AjPLA 2 gene function in vivo, development and application of AjPLA 2 protein.

genetics & heredity,biochemistry & molecular biology
Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes

Yuhuan Xie,Krishna M. Ella,Terra C. Gibbs,Marianne E. Yohannan,Stewart M. Knoepp,Pravita Balijepalli,G. Patrick Meier,Kathryn E. Meier

DOI: https://doi.org/10.3390/cells13060520

IF: 6

2024-03-17

Cells

Abstract:Lysophosphatidic acid (LPA) is a lipid mediator that binds to G-protein-coupled receptors, eliciting a wide variety of responses in mammalian cells. Lyso-phospholipids generated via phospholipase A2 (PLA2) can be converted to LPA by a lysophospholipase D (lyso-PLD). Secreted lyso-PLDs have been studied in more detail than membrane-localized lyso-PLDs. This study utilized in vitro enzyme assays with fluorescent substrates to examine LPA generation in membranes from multiple mammalian cell lines (PC12, rat pheochromocytoma; A7r5, rat vascular smooth muscle; Rat-1, rat fibroblast; PC-3, human prostate carcinoma; and SKOV-3 and OVCAR-3, human ovarian carcinoma). The results show that membranes contain a lyso-PLD activity that generates LPA from a fluorescent alkyl-lyso-phosphatidylcholine, as well as from naturally occurring acyl-linked lysophospholipids. Membrane lyso-PLD and PLD activities were distinguished by multiple criteria, including lack of effect of PLD2 over-expression on lyso-PLD activity and differential sensitivities to vanadate (PLD inhibitor) and iodate (lyso-PLD inhibitor). Based on several lines of evidence, including siRNA knockdown, membrane lyso-PLD is distinct from autotaxin, a secreted lyso-PLD. PC-3 cells express GDE4 and GDE7, recently described lyso-PLDs that localize to membranes. These findings demonstrate that membrane-associated lyso-D activity, expressed by multiple mammalian cell lines, can contribute to LPA production.

cell biology
Cloning, expression, purification and characterization of patatin, a novel phospholipase A

Hoang J. H. B. Hirschberg,Jan-Willem. F. A. Simons,Niek Dekker,Maarten R. Egmond

DOI: https://doi.org/10.1046/j.0014-2956.2001.02411.x

2001-10-01

European Journal of Biochemistry

Abstract:Patatin is the major protein constituent of potato tubers and displays broad esterase activity. The native enzyme actually belongs to a highly homologous multigene family of vacuolar glycoproteins. From these, the patB2 patatin gene was selected and cloned into pUC19 without its signal sequence but with an N-terminal histidine-tag. This patatin was overexpressed under the control of the lac promotor in Escherichia coli strain DH5alpha. The protein was recovered as inclusion bodies, folded into its native state by solubilization in urea and purified to homogeneity. Starting with one gram of inclusion bodies, 19 mg of pure and active recombinant patatin was isolated, with even higher specific activity than the glycosylated wild-type patatin purified from potato tubers. The purified enzyme showed esterolytic activity with p-nitrophenylesters dissolved in Triton X-100 micelles. The activity of patatin on p-nitrophenylesters with different carbon chain lengths showed an optimum for p-nitrophenylesters with 10 carbon atoms. Besides general esterolytic activity, the pure enzyme was found to display high phospholipase A activity in particular with the substrates 1,2-dioctanoyl-sn-glycero-3-phosphocholine (diC(8)PCho) (127 U.mg(-1)) and 1,2-dinonanoyl-sn-glycero-3-phosphocholine (diC(9)PCho) (109 U.mg(-1)). Recently, the structure of human cytosolic PLA(2) (cPLA(2)) was solved, showing a novel Ser-Asp active site dyad [1]. Based on a partial sequence alignment of patatin with human cPLA(2), we propose that patatin contains a similar active site dyad. To verify this assumption, conserved Ser, Asp and His residues in the family of patatins have been modified in patatin B2. Identification of active site residues was based on the observation of correctly folded but inactive variants. This led to the assignment of Ser54 and Asp192 as the active site serine and aspartate residues in patatin B2, respectively.

English Else
Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2

Y C Lio,E A Dennis

DOI: https://doi.org/10.1016/s0005-2760(98)00049-6

1998-06-15

Abstract:The Group VI 80-kDa Ca2+-independent phospholipase A2 (iPLA2) has been purified from murine P388D1 macrophages and Chinese hamster ovary (CHO) cells. The amino acid sequence of the iPLA2 has been determined and shown to contain a lipase consensus sequence and eight ankyrin repeats, which makes it distinct from Group I-V PLA2s. This enzyme appears to play a key role in mediating basal phospholipid remodeling. We now report that the Group VI iPLA2 displays interfacial activation toward short chain phospholipids, 1-octanoyl-2-heptanoyl-sn-glycero-3-phosphocholine, 1,2-diheptanoyl-sn-glycero-3-phosphocholine, and 1,2-dihexanoyl-sn-glycero-3-phosphocholine micelles. ATP protects the iPLA2 from a loss in activity as a result of prolonged incubation during the assay. Hence higher enzyme activity is observed in the presence than in the absence of ATP. Similar protection was obtained with glycerol. In addition, the iPLA2 exhibits multiple activities which are strongly dependent on substrate presentation. The lysophospholipase activity of this enzyme was diminished by Triton X-100 and stimulated by glycerol. With the combination of 50 microM Triton X-100 and 50% glycerol, the enzyme's lysophospholipase activity achieved equivalent activity to its PLA2 activity. The iPLA2 displayed both lysophospholipid/transacylase and phospholipid/transacylase activity, supporting the conclusion that the mechanism of action of iPLA2 proceeds through an acyl-enzyme intermediate as proposed for the Group IV cPLA2.
Purification and regiospecificity of multiple enzyme activities of phospholipase A(1) from bonito muscle

K Hirano,E Okada,T Tanaka,K Satouchi

DOI: https://doi.org/10.1016/s1388-1981(99)00190-0

2000-01-31

Abstract:Phospholipase A(1) (PLA(1)), which catalyzes the hydrolysis of the sn-1 ester bond of diacyl phospholipids, was purified from 100,000 x g supernatant of bonito muscle to homogeneity by ammonium-sulfate precipitation and four consecutive column chromatographies (DEAE anion-exchange, ether-Toyopeal, hydroxylapatite and Toyopeal HW 50S columns). The final preparation showed a single band above the 67-kDa molecular marker on SDS-PAGE, and the molecular mass was determined to be 71.5 kDa by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using bovine serum albumin as a standard for calibration. The N-terminal 8 amino residues were determined to be Ala-Pro-Ala-Glu-Lys-Val-Lys-Try. Regiospecificity of multiple enzyme activities of the PLA(1) was examined using positionally defined synthetic phosphatidylcholine (PC) and lysophosphatidylcholines (LPC). An acyl ester bond at the sn-1 position of PC was exclusively hydrolyzed by phospholipase activity, and 1-acyl LPC was cleaved to fatty acid and glycerophosphocholine by lysophospholipase (LPL) activity. However, the positional isomer, 2-acyl LPC was a poor substrate for LPL activity. PC/transacylation activity was also observed when excess 2-acyl LPC was supplied in the reaction mixture, and fatty acid at the sn-1 position of donor PC was transferred to the sn-1 position of acceptor LPC. These results demonstrate that the multiple enzyme activities of PLA(1), this is lysophospholipase, transacylase as well as phospholipase, have a strict regiospecificity at the sn-1 position of substrates.
Recent progress on acyl CoA: lysophospholipid acyltransferase research

Hideo Shindou,Daisuke Hishikawa,Takeshi Harayama,Koichi Yuki,Takao Shimizu

DOI: https://doi.org/10.1194/jlr.r800035-jlr200

IF: 6.676

2009-04-01

Journal of Lipid Research

Abstract:Cells of all organisms are enclosed by a plasma membrane containing bipolar lipids, cholesterol, and proteins. Cellular membranes contain several classes of glycerophospholipids, which have numerous structural and functional roles in cells. Polyunsaturated fatty acids including arachidonic acid and eicosapentaenoic acid are usually located at the sn-2 position, but not the sn-1 position, of glycerophospholipids in an asymmetrical manner. Glycerophospholipids are first formed by the de novo pathway (Kennedy pathway) using acyl-CoAs as donors. Subsequently, in the remodeling pathway (Lands' cycle), cycles of deacylation and reacylation of glycerophospholipids modify the fatty acid composition to generate mature membrane with asymmetry and diversity. Both pathways were proposed in the 1950s. Whereas the enzymes involved in the Kennedy pathway have been well characterized, little is known about the enzymes involved in the Lands' cycle. Recently, several laboratories, including ours, have identified enzymes working in the Lands' cycle from the 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT) family, and also from the membrane bound O-acyltransferases (MBOAT) family. These discoveries have prompted a robust surge of research in this field. In this review, we focus on the cloning and characterization of lysophospholipid acyltransferases (LPLATs), which contribute to membrane asymmetry and diversity.

biochemistry & molecular biology
Cloning and identification of human colipase-like 3 and its homologous cDNAs

LU Yan,XUE Yong-chang,YU Peng,WANG Ping-zhang

DOI: https://doi.org/10.3785/j.issn.1008-9209.2012.02.231

2012-01-01

Abstract:Although ten years have passed since the draft sequence of the human genome was reported in 2001,the accurate number of human protein-encoding genes is still uncertain.According to the latest release of H-InvDB(release 6.2),34511protein-encoding genes were annotated and most of them were function-unknown.There is still a long road ahead to identify the whole human genes and their functions.During our previous genome-wide analysis of single-block EST sequences with polyadenylation sites,we found a lot of ESTs that represented potentially novel un-identified genes or splice variants.In the present study,we focused on the cloning and identification of a novel cDNA sequence represented by the EST AV653338with the encoding product containing two incomplete colipase-like domains,when the electronic prolongation by EST contig was performed.By using mixed cDNAs from human cell lines as templates,we successfully cloned the novel encoding gene sequence,and revealed a novel human colipase-like protein-encoding gene named hCLPSL3(human colipase-like 3) for there have been two other genes with protein products also containing colipase-like domains registered in the international nucleotide databases,C6ORF126(namely CLPSL1 here) and C6ORF127(namely CLPSL2 here).Totally,two transcript variants were obtained,i.e.hCLPSL3-v1and-v2.Only hCLPSL3-v1contained a complete open reading frame(ORF),encoding 159amino acids,whereas the ORF of hCLPSL3-v2was interrupted by PTC(premature stop codon) and it possibly was a substrate of nonsense-mediated mRNA decay.Human CLPSL3-v1contained a typical signal peptide(aa.1-22) predicted by SignalP 4.0Server,two internal sequence repeat regions(aa.46-84and aa.88-125) with high homology,and two incomplete colipase-like domains(aa.2568and aa.113-159) predicted by InterProScan and Motif Scan program,respectively.Using nested RT-PCR method for expression analysis in several cell lines(293T,HeLa,U2OS,HepG2,HCT116,A549,H1299,Jurkat,H520and THP-1),we found that hCLPSL3 was mainly expressed in 293T,U2OS,HCT116and THP1cells.For lack of cDNAs,we did not perform the detection in human tissues.The typical signal peptide in CLPSL3 suggests that it probably is a secreted protein.Therefore,the recombinant eukaryotic expression vector of hCLPSL3-v1was constructed,and over-expressed in human 293Tcells.As expected,human CLPSL3 was verified to be secreted when the supernatant was used for Western blot assay.By homology analysis,mouse and rat CLPSL3 homologous cDNAs were also predicted.Using RT-PCR method,three mouse CLPSL3 transcript variants(mCLPSL-v1,-v2and-v3) were successfully cloned in the kidney(-v1),colon(-v2) and spleen(-v3) tissues,respectively.Only mCLPSL-v1contained a complete ORF encoding 161amino acids,whereas the ORFs of both mCLPSL-v2and-v3were interrupted by PTCs.Rat CLPSL3(rCLPSL3) cDNAs,encoding aproduct of 162amino acids,were successfully cloned in both colon and small intestine tissues.However,rCLPSL3 was undetectable in rat pancreas.CLPSL3 was widely expressed and highly conserved in mammalian animals,such as Pan troglodytes,Equus caballus,Cavia porcellus,Loxodonta africana,Mus musculus and Rattus norvegicus,and showed very similar gene structures.Moreover,the CLPSL3 contained 18highly conserved cysteines in all species,suggesting that it might relate to the disulfide bond formation.Colipase is a co-factor needed by pancreatic lipase for efficient dietary lipid hydrolysis.Because both mCLPSL and rCLPSL3were detectable for expression in digestive tract,whether they play important roles in dietary lipid hydrolysis still needs further investigation.Our studies lay a foundation for future functional study of CLPSL3.In addition,all of the novel nucleotide sequences have been submitted to GenBank database with the accession numbers : JQ012741(hCLPSL3-v1),JQ012742(hCLPSL3-v2),JQ258939(mCLPSL-v1),JQ258940(mCLPSLv2),JQ258941(mCLPSL-v3) and JQ258942(rCLPSL3).
Characterization of lysophospholipid metabolizing enzymes in human brain

B M Ross,S J Kish

DOI: https://doi.org/10.1046/j.1471-4159.1994.63051839.x

Abstract:Lysophospholipids are generated during the turnover and breakdown of membrane phospholipids. We have identified and partially characterized three enzymes involved in the metabolism of lysophospholipids in human brain, namely, lysophospholipase, lysophospholipid:acyl-CoA acyltransferase (acyltransferase), and lysophospholipid:lysophospholipid transacylase (transacylase). Each enzyme displayed comparable levels of activity in biopsied and autopsied human brain, although in all cases the activity was somewhat lower in human than that in rat brain. All three enzymes were localized predominantly in the particulate fraction, with lysophospholipase possessing the greatest activity followed by acyltransferase and transacylase. Lysophosphatidylcholine possessed a Km in the micromolar range for lysophospholipase and transacylase, and in the millimolar range for acyltransferase, whereas arachidonyl-CoA displayed a Km in the micromolar range for acyltransferase. The three enzymes differed in their pH optima, with lysophospholipase being most active at pH 8.0, transacylase at pH 7.5, and acyltransferase at pH 6.0. Both bromophenacyl bromide and N-ethylmaleimide inhibited lysophospholipase activity and, to a lesser extent, that of acyltransferase and transacylase. None of the enzyme activities were affected by the presence of dithiothreitol or EDTA, although particulate lysophospholipase was activated approximately two-fold by the addition of 5 mM MgCl2 or CaCl2 but not KCl. Transacylating activity was stimulated by CoA, the EC50 of activation being 6.8 microM. Acyltransferase displayed an approximately threefold preference for arachidonyl-CoA over palmitoyl-CoA, whereas the acylation rate of different lysophospholipids was in the order lysophosphatidylinositol > 1-palmitoyl lysophosphatidylcholine > 1-oleoyl lysophosphatidylcholine >> lysophosphatidylserine > lysophosphatidylethanolamine. This, and the preference of human brain phospholipase A2 for phosphatidylinositol, suggests that this phospholipid may possess a higher turnover rate than the other phospholipid classes examined. Human brain homogenates also possessed the ability to transfer fatty acid from lysophosphatidylcholine to lysophosphatidylethanolamine. In addition, we also present evidence that diacylglycerophospholipids can act as acyl donors for the transacylation of lysophospholipids. We have therefore demonstrated the presence of, and partially characterized, three enzymes that are involved in the metabolism of lysophospholipids in human brain. Our results suggest that lysophospholipase may be the major route by which lysophospholipids are removed from the cell membrane in human brain. However, all three enzymes likely play an important role in the remodeling of membrane composition and thereby contribute to the overall functioning of membrane-associated processes.
Site‐specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion

C. Fielding,C. A. Settineri,P. Schindler,A. Burlingame,X. Collet

DOI: https://doi.org/10.1002/PRO.5560040419

IF: 8

1995-04-01

Protein Science

Abstract:Site‐specific structural characterization of the glycosylation of human lecithinrcholesterol acyltransferase (LCAT) was carried out using microbore reversed‐phase high performance liquid chromatography coupled with electrospray ionization mass spectrometry (HPLC/ESIMS). A recently described mass spectrometric technique involving monitoring of carbohydrate‐specific fragment ions during HPLC/ESIMS was employed to locate eight different groups of glycopeptides in a digest of a human LCAT protein preparation. In addition to the four expected TV‐linked glycopeptides of LCAT, a di‐O‐linked glycopeptide was detected, as well as three additional glycopeptides. Structural information on the oligosaccharides from all eight glycopeptides was obtained by sequential glycosidase digestion of the glycopeptides followed by HPLC/ESIMS. All four potential N‐linked glycosylation sites (Asn20, Asn84, Asn272, and Asn384) of LCAT were determined to contain sialylated triantennary and/or biantennary complex structures. Two unanticipated O‐linked glycosylation sites were identified at Thr407 and Ser409 of the LCAT O‐linked glycopeptide, each of which contain sialylated galactoseβ13N‐acetylgalactosamine structures. The three additional glycopeptides were determined to be from a copurifying protein, apolipoprotein D, which contains potential N‐linked glycosylation sites at Asn43 and Asn78. These glycopeptides were determined to bear sialylated triantennary oligosaccharides or fucosylated sialylated biantennary oligosaccharides. Previous studies of LCAT indicated that removal of the glycosylation site at Asn272 converts this protein to a phospholipase (Francone OL, Evangelista L, Fielding CJ, 1993, Biochim Biophys Acta 7766:301–304). Our results indicate that the carbohydrate structures themselves are not the source of this functional discrimination; rather, it must be mediated by the structural environment around Asn272.

Chemistry,Medicine,Biology
A Novel Acyl-CoA Synthetase, ACS5, Expressed in Intestinal Epithelial Cells and Proliferating Preadipocytes

E. Oikawa,H. Iijima,T. Suzuki,H. Sasano,H. Sato,A. Kamataki,H. Nagura,M.-J. Kang,T. Fujino,H. Suzuki,T. T. Yamamoto

DOI: https://doi.org/10.1093/oxfordjournals.jbchem.a022165

1998-09-01

Abstract:We report here the identification, characterization, and expression of a novel rat acyl-CoA synthetase (ACS) designated as ACS5. ACS5 consists of 683 amino acids and is approximately 60% identical to the previously characterized ACS1 and ACS2. ACS5 was overproduced in Escherichia coli cells and then purified to near homogeneity. The purified enzyme utilized a wide range of saturated fatty acids similar to those utilized by ACS1 and ACS2, but differed in its preference for C16-C18 unsaturated fatty acids. Northern blot analysis revealed that ACS5 mRNA is present most abundantly in the small intestine, and to a much lesser extent in the lung, liver, adrenal gland, adipose tissue, and kidney. In situ hybridization of rat ileum revealed abundant accumulation of ACS5 transcripts in foveolar epithelial cells. The hepatic level of ACS5 mRNA was significantly increased by refeeding a fat-free high sucrose diet and reduced by fasting or refeeding a high cholesterol diet, whereas that in the small intestine was not significantly altered by various dietary conditions. In contrast to the absence of ACS1 mRNA in undifferentiated 3T3-L1 preadipocytes, ACS5 mRNA was present in proliferating 3T3-L1 preadipocytes and its level remained unaltered during differentiation, suggesting that ACS5 may provide the acyl-CoA utilized for the synthesis of cellular lipids in proliferating preadipocytes.

biochemistry & molecular biology

An alternative approach to myelodysplasia management: aggressive observation and prompt intervention.

A turn in the road: How studies on the pharmacology of glucosylceramide synthase inhibitors led to the identification of a lysosomal phospholipase A2 with ceramide transacylase activity

Identification and Functional Analysis of Cytosolic Phospholipase A2 (cpla2) from the Red Swamp Crayfish Procambarus Clarkii: the First Evidence of Cpla2 Involved in Immunity in Invertebrates.

Cloning and Characterization of an Oxiranedicarboxylate Hydrolase from Labrys Sp. WH-1

Heterologous Expression, Refolding, and Characterization of a Calcium-Independent Phospholipase A1 from Streptomyces Albidoflavus

Overexpression, purification and characterization of phospholipase C from Acinetobacter calcoaceticus

Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.

Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice.

Characterization of the transacylase activity of rat liver 60-kDa lysophospholipase-transacylase. Acyl transfer from the sn-2 to the sn-1 position

Role of conserved active site residues in catalysis by phospholipase B1 from Cryptococcus neoformans

Mammalian Long-Chain Acyl-CoA Synthetases

Molecular Cloning and Functional Analysis of Secretory Phospholipase A2 from Apostichopus japonicus

Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes

Cloning, expression, purification and characterization of patatin, a novel phospholipase A

Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2

Purification and regiospecificity of multiple enzyme activities of phospholipase A(1) from bonito muscle

Recent progress on acyl CoA: lysophospholipid acyltransferase research

Cloning and identification of human colipase-like 3 and its homologous cDNAs

Characterization of lysophospholipid metabolizing enzymes in human brain

Site‐specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion

A Novel Acyl-CoA Synthetase, ACS5, Expressed in Intestinal Epithelial Cells and Proliferating Preadipocytes